908 Devices Inc. (MASS)

Market Cap	186.36M
Revenue (ttm)	50.73M
Net Income (ttm)	-34.79M
Shares Out	32.98M
EPS (ttm)	-1.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	252,659
Open	5.86
Previous Close	5.67
Day's Range	5.60 - 6.07
52-Week Range	4.85 - 12.51
Beta	0.93
Analysts	Buy
Price Target	14.00 (+147.79%)
Earnings Date	Apr 30, 2024

About MASS

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracel...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Dec 18, 2020
• Employees: 230
• Stock Exchange: NASDAQ
• Ticker Symbol: MASS

Financial Performance

In 2023, 908 Devices's revenue was $50.23 million, an increase of 7.21% compared to the previous year's $46.85 million. Losses were -$36.40 million, 8.45% more than in 2022.

Analyst Forecast

According to one analyst, the rating for MASS stock is "Buy" and the 12-month stock price forecast is $14.0.

Price Target

$14.0

(147.79% upside)

Analyst Consensus: Buy